Apeiron Investments

Apeiron Investment Group is the family office and merchant banking business of entrepreneur Christian Angermayer, specializing in life sciences and deep tech. The firm is a primary driver of the psychedelic medicine sector, having co-founded and anchored ATAI Life Sciences to develop treatments for mental health disorders. Apeiron also maintains a significant strategic focus on longevity and regenerative medicine through its investments in platforms like Cambrian BioPharma and Rejuveron Life Sciences. Operating globally with a presence in Malta, London, Berlin, and New York, the group provides capital across the entire corporate lifecycle, from seed funding to IPO. Apeiron is distinguished by its company-builder model, often taking an active role in the formation and strategic direction of its core portfolio companies.